Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.
Hyperion Functional Medicine introduces a transformative approach to cancer care through its Functional Oncology program, designed to optimize treatment, ...
Transferrin receptor 1 (TfR1) has been shown to be upregulated in nasopharyngeal carcinoma (NPC). Here the authors report that TfR1 can be targeted in hypoxic NPC lesions using ferritin nanozymes.